1. Home
  2. Stock quotes
  3. Stock VYNE Therapeutics
VYNE Therapeutics logo

VYNE Therapeutics VYNE

$ 0.68 1.21%

Quarterly report 2026-Q1
added 05-15-2026

report update icon

Country

 usaUSA

IPO year

 2018

Industry

 -

Stock Exchange

 NASDAQ GLOBAL

Shares

 42.8 M

Market Cap[1]

 $ 29.1 M

EBITDA (LTM)

 $ -29.6 M

P/E (LTM)

 -0.96

P/S (LTM)

 59.7

EPS (LTM)

 -0.7

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.